We performed comparative transcriptomic analysis of KRAS-mutant versus wild-type CRC epithelial cells using single-cell RNA sequencing data from a published cohort 13, in which mutational status was validated through targeted cDNA Sanger sequencing at single-cell resolution. This evidence concerns the gene KRAS and colorectal carcinoma.